Cue Biopharma Inc (CUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -26,294 | -13,109 | -53,010 | -38,418 | -27,463 |
| Depreciation Amortization | 109 | 37 | 632 | 639 | 530 |
| Accounts receivable | -1,077 | -139 | 3,085 | 2,347 | 2,407 |
| Other Working Capital | -533 | -493 | 356 | -1,226 | -2,766 |
| Other Operating Activity | 6,591 | 2,871 | 7,131 | 5,366 | 2,871 |
| Operating Cash Flow | $-21,204 | $-10,833 | $-41,806 | $-31,292 | $-24,421 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 20,000 | 15,000 | -24,445 | -29,445 | N/A |
| PPE Investments | 2 | 2 | -165 | -164 | -89 |
| Investing Cash Flow | $20,002 | $15,002 | $-24,610 | $-29,609 | $-89 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 10,000 | 10,000 | 10,000 |
| Common Stock Issued | 473 | 388 | 22,702 | N/A | N/A |
| Other Financing Activity | 2,016 | 0 | 20,957 | 16,256 | 16,265 |
| Financing Cash Flow | $2,489 | $388 | $53,659 | $26,256 | $26,265 |
| Beginning Cash Position | 51,764 | 51,764 | 64,521 | 64,521 | 64,521 |
| End Cash Position | 53,051 | 56,321 | 51,764 | 29,876 | 66,276 |
| Net Cash Flow | $1,287 | $4,557 | $-12,757 | $-34,645 | $1,755 |
| Free Cash Flow | |||||
| Operating Cash Flow | -21,204 | -10,833 | -41,806 | -31,292 | -24,421 |
| Capital Expenditure | N/A | N/A | -171 | -170 | -92 |
| Free Cash Flow | -21,204 | -10,833 | -41,977 | -31,462 | -24,513 |